NYSE:AGN - Allergan Stock Price, News & Analysis

Allergan trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGN."

Allergan announced a quarterly dividend on Friday, July 19th. Investors of record on Tuesday, August 13th will be paid a dividend of $0.74 per share on Friday, September 13th. This represents a $2.96 annualized dividend and a yield of 1.79%. The ex-dividend date is Monday, August 12th. View Allergan's Dividend History.

Allergan declared that its Board of Directors has initiated a stock repurchase program on Tuesday, January 29th 2019, which allows the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 4.1% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's leadership believes its shares are undervalued.

Allergan plc (NYSE:AGN) released its quarterly earnings results on Tuesday, August, 6th. The company reported $4.38 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $4.34 by $0.04. The firm had revenue of $4.09 billion for the quarter, compared to analyst estimates of $3.93 billion. Allergan had a negative net margin of 54.25% and a positive return on equity of 8.73%. The firm's revenue for the quarter was down .8% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.42 earnings per share. View Allergan's Earnings History.

Allergan is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Allergan.

Allergan issued an update on its FY19 earnings guidance on Tuesday, August, 6th. The company provided EPS guidance of >$16.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $16.74. The company issued revenue guidance of 15.4-15.6 billion, compared to the consensus revenue estimate of $15.32 billion.

21 Wall Street analysts have issued 1-year price objectives for Allergan's stock. Their forecasts range from $144.95 to $255.00. On average, they expect Allergan's share price to reach $178.7515 in the next year. This suggests a possible upside of 7.9% from the stock's current price. View Analyst Price Targets for Allergan.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allergan in the last year. There are currently 15 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Allergan.

News stories about AGN stock have trended negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Allergan earned a news sentiment score of -2.9 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Allergan.

Allergan saw a increase in short interest in August. As of August 31st, there was short interest totalling 7,261,500 shares, an increase of 22.5% from the July 31st total of 5,926,900 shares. Based on an average daily volume of 4,930,000 shares, the days-to-cover ratio is currently 1.5 days. Approximately 2.2% of the shares of the company are sold short. View Allergan's Current Options Chain.

Some companies that are related to Allergan include Merck & Co., Inc. (MRK), Pfizer (PFE), Novartis (NVS), Abbott Laboratories (ABT), Novo Nordisk A/S (NVO), Sanofi (SNY), AstraZeneca (AZN), Eli Lilly And Co (LLY), AbbVie (ABBV), GlaxoSmithKline (GSK), Bristol-Myers Squibb (BMY), Commonwealth Bank of Australia (CSLLY), Celgene (CELG), Bayer (BAYRY) and Zoetis (ZTS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allergan investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Micron Technology (MU), Aegean Marine Petroleum Network (ANW), NIC (EGOV), United Rentals (URI) and Transocean (RIG).

Allergan's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.36%), BlackRock Inc. (6.04%), BlackRock Inc. (6.04%), Longview Partners Guernsey LTD (2.13%), Northern Trust Corp (1.21%) and Baupost Group LLC MA (1.12%). Company insiders that own Allergan stock include Brent L Saunders, Chris W Bodine, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado, Matthew M Walsh and William Meury. View Institutional Ownership Trends for Allergan.

AGN stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, Janus Henderson Group PLC, King Street Capital Management L.P., Iridian Asset Management LLC CT, Baupost Group LLC MA, BlackRock Inc., BlackRock Inc. and Invesco Ltd.. View Insider Buying and Selling for Allergan.

AGN stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Magnetar Financial LLC, OZ Management LP, Paulson & CO. Inc., Longview Partners Guernsey LTD, Alpine Associates Management Inc., TIG Advisors LLC and TIG Advisors LLC. Company insiders that have bought Allergan stock in the last two years include Brent L Saunders, Chris W Bodine, Christopher J Coughlin, Joseph H Boccuzi, Maria Teresa Hilado and Matthew M Walsh. View Insider Buying and Selling for Allergan.

Shares of AGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AGN stock can currently be purchased for approximately $165.73.

Allergan has a market capitalization of $54.36 billion and generates $15.79 billion in revenue each year. The company earns $-5,096,400,000.00 in net income (profit) each year or $16.69 on an earnings per share basis. Allergan employs 16,900 workers across the globe.View Additional Information About Allergan.

The official website for Allergan is http://www.allergan.com/.

Allergan's mailing address is CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2, D17 E400. The company can be reached via phone at 862-261-7000 or via email at [email protected]